BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

243 related articles for article (PubMed ID: 8389916)

  • 1. The lytic origin of herpesvirus papio is highly homologous to Epstein-Barr virus ori-Lyt: evolutionary conservation of transcriptional activation and replication signals.
    Ryon JJ; Fixman ED; Houchens C; Zong J; Lieberman PM; Chang YN; Hayward GS; Hayward SD
    J Virol; 1993 Jul; 67(7):4006-16. PubMed ID: 8389916
    [TBL] [Abstract][Full Text] [Related]  

  • 2. trans-acting requirements for replication of Epstein-Barr virus ori-Lyt.
    Fixman ED; Hayward GS; Hayward SD
    J Virol; 1992 Aug; 66(8):5030-9. PubMed ID: 1321285
    [TBL] [Abstract][Full Text] [Related]  

  • 3. EBNA-2 of herpesvirus papio diverges significantly from the type A and type B EBNA-2 proteins of Epstein-Barr virus but retains an efficient transactivation domain with a conserved hydrophobic motif.
    Ling PD; Ryon JJ; Hayward SD
    J Virol; 1993 Jun; 67(6):2990-3003. PubMed ID: 8388484
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Plasmid origin of replication of herpesvirus papio: DNA sequence and enhancer function.
    Loeb DD; Sung NS; Pesano RL; Sexton CJ; Hutchison C; Pagano JS
    J Virol; 1990 Jun; 64(6):2876-83. PubMed ID: 2159548
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The zta transactivator involved in induction of lytic cycle gene expression in Epstein-Barr virus-infected lymphocytes binds to both AP-1 and ZRE sites in target promoter and enhancer regions.
    Lieberman PM; Hardwick JM; Sample J; Hayward GS; Hayward SD
    J Virol; 1990 Mar; 64(3):1143-55. PubMed ID: 2154599
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Kaposi's sarcoma-associated herpesvirus ori-Lyt-dependent DNA replication: cis-acting requirements for replication and ori-Lyt-associated RNA transcription.
    Wang Y; Li H; Chan MY; Zhu FX; Lukac DM; Yuan Y
    J Virol; 2004 Aug; 78(16):8615-29. PubMed ID: 15280471
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A replication function associated with the activation domain of the Epstein-Barr virus Zta transactivator.
    Sarisky RT; Gao Z; Lieberman PM; Fixman ED; Hayward GS; Hayward SD
    J Virol; 1996 Dec; 70(12):8340-7. PubMed ID: 8970953
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Kaposi's sarcoma-associated herpesvirus lytic origin (ori-Lyt)-dependent DNA replication: identification of the ori-Lyt and association of K8 bZip protein with the origin.
    Lin CL; Li H; Wang Y; Zhu FX; Kudchodkar S; Yuan Y
    J Virol; 2003 May; 77(10):5578-88. PubMed ID: 12719550
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Transcriptional activation signals found in the Epstein-Barr virus (EBV) latency C promoter are conserved in the latency C promoter sequences from baboon and Rhesus monkey EBV-like lymphocryptoviruses (cercopithicine herpesviruses 12 and 15).
    Fuentes-PananĂ¡ EM; Swaminathan S; Ling PD
    J Virol; 1999 Jan; 73(1):826-33. PubMed ID: 9847397
    [TBL] [Abstract][Full Text] [Related]  

  • 10. An enhancer within the divergent promoter of Epstein-Barr virus responds synergistically to the R and Z transactivators.
    Cox MA; Leahy J; Hardwick JM
    J Virol; 1990 Jan; 64(1):313-21. PubMed ID: 2152819
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CCAAT/enhancer binding protein alpha binds to the Epstein-Barr virus (EBV) ZTA protein through oligomeric interactions and contributes to cooperative transcriptional activation of the ZTA promoter through direct binding to the ZII and ZIIIB motifs during induction of the EBV lytic cycle.
    Wu FY; Wang SE; Chen H; Wang L; Hayward SD; Hayward GS
    J Virol; 2004 May; 78(9):4847-65. PubMed ID: 15078966
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Kaposi's sarcoma-associated herpesvirus ori-Lyt-dependent DNA replication: dual role of replication and transcription activator.
    Wang Y; Tang Q; Maul GG; Yuan Y
    J Virol; 2006 Dec; 80(24):12171-86. PubMed ID: 17020951
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of the EBNA1 proteins of Epstein-Barr virus and herpesvirus papio in sequence and function.
    Yates JL; Camiolo SM; Ali S; Ying A
    Virology; 1996 Aug; 222(1):1-13. PubMed ID: 8806482
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Herpesvirus papio contains a plasmid origin of replication that acts in cis interspecies with an Epstein-Barr virus trans-acting function.
    Pesano RL; Pagano JS
    J Virol; 1986 Dec; 60(3):1159-62. PubMed ID: 3023667
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lytic cycle gene regulation of Epstein-Barr virus.
    Amon W; Binné UK; Bryant H; Jenkins PJ; Karstegl CE; Farrell PJ
    J Virol; 2004 Dec; 78(24):13460-9. PubMed ID: 15564457
    [TBL] [Abstract][Full Text] [Related]  

  • 16. 5' Coding and regulatory region sequence divergence with conserved function of the Epstein-Barr virus LMP2A homolog in herpesvirus papio.
    Franken M; Annis B; Ali AN; Wang F
    J Virol; 1995 Dec; 69(12):8011-9. PubMed ID: 7494314
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Origin-independent assembly of Kaposi's sarcoma-associated herpesvirus DNA replication compartments in transient cotransfection assays and association with the ORF-K8 protein and cellular PML.
    Wu FY; Ahn JH; Alcendor DJ; Jang WJ; Xiao J; Hayward SD; Hayward GS
    J Virol; 2001 Feb; 75(3):1487-506. PubMed ID: 11152521
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparative studies of herpesvirus papio (baboon herpesvirus) DNA and Epstein-Barr virus DNA.
    Lee YS; Tanaka A; Lau RY; Nonoyama M; Rabin H
    J Gen Virol; 1980 Dec; 51(Pt 2):245-53. PubMed ID: 6262436
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Epstein-Barr virus R transactivator (Rta) contains a complex, potent activation domain with properties different from those of VP16.
    Hardwick JM; Tse L; Applegren N; Nicholas J; Veliuona MA
    J Virol; 1992 Sep; 66(9):5500-8. PubMed ID: 1323708
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CCAAT/enhancer binding protein alpha interacts with ZTA and mediates ZTA-induced p21(CIP-1) accumulation and G(1) cell cycle arrest during the Epstein-Barr virus lytic cycle.
    Wu FY; Chen H; Wang SE; ApRhys CM; Liao G; Fujimuro M; Farrell CJ; Huang J; Hayward SD; Hayward GS
    J Virol; 2003 Jan; 77(2):1481-500. PubMed ID: 12502863
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.